biotech

Equities

The New Criterion: two ways to play the pain game

Independent Investment Research

Expert Insights • sponsored

Paradigm: Deep value in a small-cap biotech?

Livewire Exclusive

Livewire

Equities

Alzheimer's: No Surprises

Frazis Capital Partners

Deep Diving For Asymmetric Upside - New Idea

Fiftyone Capital

Expert Insights

A profound med-tech breakthrough

Livewire Exclusive

Livewire

Podcasts

The Rules of Investing: The Age of Longevity

Livewire Exclusive

Livewire

Biotech stocks: the animal spirits are back

Independent Investment Research

Speculative Bubbles

Michael Glennon

Glennon Capital

A biotech that's been misunderstood

Livewire Exclusive

Livewire

Lifesciences: Give your portfolio a booster shot

Livewire